Compare LVRO & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LVRO | NTRB |
|---|---|---|
| Founded | 2017 | 2016 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 68.2M | 71.7M |
| IPO Year | N/A | N/A |
| Metric | LVRO | NTRB |
|---|---|---|
| Price | $0.52 | $4.61 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 3 | 1 |
| Target Price | $1.88 | ★ $13.00 |
| AVG Volume (30 Days) | 15.8K | ★ 58.9K |
| Earning Date | 02-02-2026 | 12-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,667,345,189.00 | $2,278,321.00 |
| Revenue This Year | N/A | $30.17 |
| Revenue Next Year | $11.45 | $3,394.36 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 12.69 |
| 52 Week Low | $0.41 | $3.76 |
| 52 Week High | $5.60 | $11.78 |
| Indicator | LVRO | NTRB |
|---|---|---|
| Relative Strength Index (RSI) | 22.31 | 46.41 |
| Support Level | $0.41 | $4.34 |
| Resistance Level | $0.68 | $6.41 |
| Average True Range (ATR) | 0.09 | 0.51 |
| MACD | 0.01 | 0.10 |
| Stochastic Oscillator | 12.77 | 20.29 |
Lavoro Ltd operates in the agricultural inputs retail market, with operations spread across Brazil and Colombia, and an emergent agricultural input trading company in Uruguay. The reportable segments of the company include the Brazil Ag Retail, which comprises companies dedicated to the distribution of agricultural inputs such as crop protection, seeds, fertilizers and specialty products, in Brazil; Latam Ag Retail, which includes companies dedicated to the distribution of agricultural inputs outside Brazil (predominantly in Colombia); and the Crop Care. A substantial part of the company's overall revenue is generated from its Brazil Ag Retail segment.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.